Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Fallopian Tubes”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Looking for participantsNCT06856499
What this trial is testing

Cirtuvivint/Olaparib in Breast Cancer Susceptibility Gene/Homologous Recombination Deficiency Platinum Resistant Ovarian Cancer

Who this might be right for
Endometrioid Ovarian CancerPrimary Peritoneal CancerFallopian Tube Cancer
University of Colorado, Denver 50
Very early researchEnded earlyNCT02411565
What this trial is testing

Fermented Wheat Germ Extract in Women With Ovarian Cancer

Who this might be right for
Ovarian Cancer
H. Lee Moffitt Cancer Center and Research Institute 3
Very early researchStudy completedNCT01670799
What this trial is testing

Availability & Effect of Post-OP Ketorolac on Ovarian, Fallopian Tube or Primary Peritoneal Cancer

Who this might be right for
Fallopian Tube CancerOvarian CancerPeritoneal Cavity Cancer
New Mexico Cancer Research Alliance 29
Testing effectiveness (Phase 2)Ended earlyNCT05949632
What this trial is testing

INCB099280 in Combination With Axitinib in Adults With Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumors
Incyte Corporation 5
Testing effectiveness (Phase 2)UnknownNCT04556071
What this trial is testing

Efficacy and Safety of Niraparib Combined With Bevacizumab in Platinum Refractory/Resistant Recurrent Ovarian Cancer

Who this might be right for
Ovarian NeoplasmsFallopian Tube NeoplasmsEndocrine Gland Neoplasms+21 more
Xiaoxiang Chen 32
Not applicableLooking for participantsNCT00005095
What this trial is testing

Specimen and Data Study for Ovarian Cancer Early Detection and Prevention

Who this might be right for
Cervical CancerEndometrial CancerFallopian Tube Cancer+6 more
Northwestern University 6,000
Testing effectiveness (Phase 2)Active Not RecruitingNCT05465941
What this trial is testing

PLX038 for Treatment of Metastatic Platinum-resistant Ovarian, Primary Peritoneal, and Fallopian Tube Cancer

Who this might be right for
Platinum-Resistant Fallopian Tube CarcinomaPlatinum-Resistant Ovarian CarcinomaPlatinum-Resistant Primary Peritoneal Carcinoma+3 more
Mayo Clinic 20
Large-scale testing (Phase 3)Ended earlyNCT01493505
What this trial is testing

TRINOVA-3: A Study of AMG 386 or AMG 386 Placebo in Combination With Paclitaxel and Carboplatin to Treat Ovarian Cancer

Who this might be right for
Fallopian Tube CancerOvarian CancerPeritoneal Cancer
Amgen 1,015
Testing effectiveness (Phase 2)Study completedNCT00002538
What this trial is testing

Laparoscopic Staging in Patients With Ovarian, Fallopian Tube, or Other Primary Abdominal Cancers

Who this might be right for
Fallopian Tube CancerOvarian CancerPrimary Peritoneal Cavity Cancer
Gynecologic Oncology Group
Testing effectiveness (Phase 2)Study completedNCT00888615
What this trial is testing

Elesclomol Sodium and Paclitaxel in Treating Patients With Recurrent or Persistent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer

Who this might be right for
Fallopian Tube Clear Cell AdenocarcinomaFallopian Tube Endometrioid AdenocarcinomaFallopian Tube Mucinous Adenocarcinoma+15 more
GOG Foundation 58
Testing effectiveness (Phase 2)Study completedNCT03759587
What this trial is testing

Japan Phase 2 Study of Niraparib (Maintenance Therapy) in Participants With Relapsed Ovarian Cancer

Who this might be right for
Ovarian CancerFallopian Tube CancerPrimary Peritoneal Cancer
Takeda 19
Testing effectiveness (Phase 2)Looking for participantsNCT06735326
What this trial is testing

Fluzoparib With or Without Bevacizumab for Neoadjuvant Therapy in Advanced Ovarian Cancer

Who this might be right for
Ovarian CancerFallopian Tube CancerPeritoneal Cancer
Qilu Hospital of Shandong University 105
Testing effectiveness (Phase 2)UnknownNCT02595021
What this trial is testing

Total/Subtotal Colectomy in Ovarian Cancer

Who this might be right for
Epithelial Ovarian CancerFallopian Tube CancerPrimary Peritoneal Carcinoma+1 more
Shanghai Gynecologic Oncology Group 80
Not applicableNot Yet RecruitingNCT05921149
What this trial is testing

Fasting Mimicking Diet (FMD) in Conjunction With Chemotherapy in Advanced Ovarian Cancer

Who this might be right for
Ovarian CancerChemotherapeutic Toxicity
Endeavor Health 170
Testing effectiveness (Phase 2)Study completedNCT00993655
What this trial is testing

Intraperitoneal vs Intravenous Chemotherapy Following Neoadjuvant Chemotherapy in Ovarian Cancer

Who this might be right for
Fallopian Tube CancerMetastatic CancerOvarian Cancer+1 more
Canadian Cancer Trials Group 275
Not applicableStudy completedNCT00870233
What this trial is testing

Outcomes From Home in Patients Recovering From Major Gynecologic Cancer Surgery: Measuring Symptoms and Health-related Quality of Life

Who this might be right for
Fallopian Tube CancerOvarian CancerPeritoneal Cancer+3 more
Memorial Sloan Kettering Cancer Center 120
Very early researchStudy completedNCT01132014
What this trial is testing

Autologous OC-DC Vaccine in Ovarian Cancer

Who this might be right for
ChemotherapyTumorOvarian Cancer
Abramson Cancer Center at Penn Medicine 67
Testing effectiveness (Phase 2)Study completedNCT01306032
What this trial is testing

Phase II ABT-888 With Cyclophosphamide

Who this might be right for
Ovarian CancerPrimary Peritoneal CancerSerous Carcinoma Cancer+2 more
National Cancer Institute (NCI) 124
Early research (Phase 1)Study completedNCT02118285
What this trial is testing

Intraperitoneal Natural Killer Cells and INCB024360 for Recurrent Ovarian, Fallopian Tube, and Primary Peritoneal Cancer

Who this might be right for
Ovarian CancerFallopian Tube CarcinomaPrimary Peritoneal Carcinoma
Masonic Cancer Center, University of Minnesota 2
Not applicableWithdrawnNCT01053052
What this trial is testing

Study of FemVue(TM) Sono Tubal Evaluation System Method Comparison to HSG

Who this might be right for
Fallopian Tube Patency Tests
Femasys Inc.
Next Page